SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?


To: Gurupup who wrote (2220)5/21/1998 2:27:00 PM
From: Cacaito  Read Replies (3) | Respond to of 5736
 
I tested the Colormate in myself at the New Orleans meeting, very neat.

The Bilicheck from SPRX was there too, they are expecting The FDA approval in the next few months, but Colormate is ahead.

In the USA some 3000 newborn units, probably a smaller number (the major market).

Each unit will have probably two available at any time.

Each Colormate will cost about $3000 ( what I remember from either the CCSI or SPRX people at the boosts).

Then one have an $18,000,000 market, double that for the whole world.

Assume a 20% annual penetrance for 5 years and one gets about
$3 to $5 million in sales a year, lets imagine a 50% net and it will give you $1.5 to 2.5 million a year profits, divide that for the number of shares (4 million ?) and it is about $0.25 to $0.50 earnings
per share first year. If a PE of 30 (for a 30% to 50% annual growth in profits) and you have a 30 x 0.5 share.

Next year value per share $15.

If the market pays for the rest of the technology at hand you will get couple of more dollars (less say $5 more.) $20 a share for 1999.

All this without competition from SPRX which already started shipping their product outside of the USA.

1999 will bring you a $12 stock price.

Important, insurance companies will (as far as I know) reimburse physicians and hospitals for the tests done with the Colormate, this will make it easier for them to buy.